Categories
Research Insights
NIH: Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging findings in ARIA (U24 – Clinical Trials Not Allowed)
This program promotes the development and distribution of innovative technologies, methods, protocols, and biomedical materials that enhance combined human neuropathology and neuroimaging research aimed at understanding the vascular pathogenesis and pathophysiology of anti-Aβ monoclonal antibody induced Amyloid Related Imaging Abnormalities.
Amount: $7,550,000
Due Date: 04/30/2024 (LOI); 05/31/2024 (Full Proposal)